nitrosomethylurethane has been researched along with picibanil in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ebine, N; Ishii, S; Matsuno, S; Nukata, Y; Shiiba, K | 1 |
1 other study(ies) available for nitrosomethylurethane and picibanil
Article | Year |
---|---|
[Oral administration of OK-432 is an effective immunotherapy against colon cancer--a study in a murine mesenteric lymphnode metastasis model].
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Colonic Neoplasms; Immunotherapy; Lymphatic Metastasis; Male; Mesentery; Mice; Mice, Inbred BALB C; Nitrosomethylurethane; Picibanil | 1995 |